FilingSEC EDGAR8-K
Oramed Pharmaceuticals Approves Increase in Stock Incentive Plan at Annual Meeting
· SEC accepted
StageApproval
Filing content
The company held its 2026 Annual Meeting, where stockholders re-elected directors, ratified the auditor, and approved an amendment to increase the 2019 Stock Incentive Plan by 3 million shares.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…